Cargando…
Abatacept is effective in Chinese patients with LRBA and CTLA4 deficiency
CTLA4 deficiency and LRBA deficiency are a group disorders of immune dysregulation that affect CTLA4 pathway. The patients mainly present with autoimmunity, antibody deficiency and recurrent infections. Here we reported three Chinese patients with LRBA and CTLA4 mutations. They all presented with ch...
Autores principales: | Yang, Lu, Xue, Xiuhong, Chen, Xuemei, Wu, Junfeng, Yang, Xi, Xu, Li, Tang, Xuemei, Wang, Mo, Mao, Huawei, Zhao, Xiaodong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278529/ https://www.ncbi.nlm.nih.gov/pubmed/34291137 http://dx.doi.org/10.1016/j.gendis.2020.03.001 |
Ejemplares similares
-
Case Report: Refractory Autoimmune Gastritis Responsive to Abatacept in LRBA Deficiency
por: Boz, Valentina, et al.
Publicado: (2021) -
Regulation of CTLA‐4 recycling by LRBA and Rab11
por: Janman, Daniel, et al.
Publicado: (2021) -
Murine LRBA deficiency causes CTLA-4 deficiency in Tregs without progression to immune dysregulation
por: Burnett, Deborah L, et al.
Publicado: (2017) -
The ABACHAI clinical trial protocol: Safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: A non controlled phase 2 clinical trial
por: Krausz, Máté, et al.
Publicado: (2022) -
A heterozygous N-terminal truncation mutation of NFKBIA results in an impaired NF-κB dependent inflammatory response
por: Wen, Wen, et al.
Publicado: (2021)